Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Jan 09, 2020

SELL
$57.36 - $124.1 $456,241 - $987,091
-7,954 Closed
0 $0
Q2 2019

Jul 18, 2019

BUY
$77.77 - $120.68 $27,530 - $42,720
354 Added 4.66%
7,954 $633,000
Q1 2019

Apr 09, 2019

BUY
$91.83 - $120.68 $697,908 - $917,168
7,600 New
7,600 $850,000

Others Institutions Holding ICPT

About INTERCEPT PHARMACEUTICALS, INC.


  • Ticker ICPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,127,400
  • Description
  • Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...
More about ICPT
Track This Portfolio

Track Private Capital Advisors, Inc. Portfolio

Follow Private Capital Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Capital Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Private Capital Advisors, Inc. with notifications on news.